New York Attorney General Eric Schneiderman says New York will get $61 million from last week’s national settlement with drug maker Merck & Co. to resolve an investigation into the marketing of the painkiller Vioxx.
A federal court has accepted Merck’s guilty plea to one misdemeanor count of violating marketing laws.
The Justice Department says the Whitehouse Station, N.J., company marketed Vioxx as a treatment for rheumatoid arthritis without federal approval for almost three years and made false settlements about its cardiovascular safety.
The drug was taken off the market in September 2004 after evidence showed it doubled the risk of heart attack and stroke.
The company says the government recognized Merck’s cooperation, and it recorded a $950 million charge in October 2010 in anticipation of the settlement agreements.
Cyber Attacks On Banks More Serious Than Public Realizes
E&O Insights: Restaurant and Tavern Risks
CEA’s First CIO Reflects C-Suite Trend
Golf and Country Clubs Weather the Storm
Midwest AGs Go After Storm-Chasing Roofing Companies
Medical Malpractice Payouts Not Driving Up Health Costs: Study
Florida Lawmakers Approve Medical Malpractice Reform
Industry Results Show Positive Signs for Workers’ Comp Line, NCCI’s Chief Economist Says
Sign up to receive insurance news alerts!
